A PIVOTAL PHASE II/III, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED TRIAL OF QPI-1007 DELIVERED BY MULTI-DOSE INTRAVITREAL INJECTIONS TO SUBJECTS WITH ACUTE NON ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY (NAION) -- QRK 207
Clinical Trial Grant
Administered By
Ophthalmology, Neuro-Ophthalmology
Awarded By
Quark Pharmaceuticals, Inc
Start Date
January 1, 2016
End Date
December 31, 2020
Administered By
Ophthalmology, Neuro-Ophthalmology
Awarded By
Quark Pharmaceuticals, Inc
Start Date
January 1, 2016
End Date
December 31, 2020